STOCK TITAN
  1. Home
  2. News
  3. AIMD

Ainos Inc - AIMD STOCK NEWS

IMPACT
SENTIMENT
AIMD : Nasdaq AIMDW : Nasdaq
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
IMPACT
SENTIMENT
AIMD : Nasdaq AIMDW : Nasdaq
Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
clinical trial
IMPACT
SENTIMENT
AIMD : Nasdaq AIMDW : Nasdaq
Ainos Reports Third Quarter 2023 Financial Results
earnings
IMPACT
SENTIMENT
AIMD : Nasdaq AIMDW : Nasdaq
Ainos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONA
clinical trial
IMPACT
SENTIMENT
AIMD : Nasdaq AIMDW : Nasdaq
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
IMPACT
SENTIMENT
AIMD : Nasdaq
With Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV Patients
clinical trial
IMPACT
SENTIMENT
AIMD : Nasdaq AIMDW : Nasdaq
Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients
clinical trial
IMPACT
SENTIMENT
AIMD : Nasdaq AIMDW : Nasdaq
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan
IMPACT
SENTIMENT
AIMD : Nasdaq
Ainos, Inc - The AI Nose "Knows" What's Inside Your Body and Beyond
AI
IMPACT
SENTIMENT
AIMD : Nasdaq AIMDW : Nasdaq
Ainos Reports Second Quarter 2023 Financial Results
earnings
Stock AIMD logo
Ainos Inc

Nasdaq:AIMD

AIMD Rankings

#7305 Ranked by Market Cap
#4538 Ranked by Stock Gains
N/A Ranked by Dividends

AIMD Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing